| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1,3750 | +0,37% | $219,39M | $504,71K | |
| $2,8200 | +1,08% | $217,47M | $7,000 | |
MFM Aberdeen Municipal Income Fund | $5,2700 | +0,00% | $217,47M | $187,37K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,8150 | -0,74% | $217,46M | $38,22K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $10,0000 | +0,60% | $217,43M | $11,00 | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5,8200 | +0,00% | $217,14M | $45,11K | |
EXFY Expensify, Inc. Class A Common Stock | $2,3800 | +0,42% | $217,02M | $417,55K | |
| $62,8400 | -0,24% | $216,79M | $18,29K | |
IIF Morgan Stanley India Investment Fund, Inc. | $22,8100 | +0,00% | $216,64M | $30,78K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3,3800 | -0,59% | $216,27M | $23,00 | |
MITT TPG Mortgage Investment Trust, Inc. | $6,7800 | +0,00% | $216,26M | $216,24K | |
| $1,5600 | +0,00% | $215,73M | $2,50K | |
PEPG PepGen Inc. Common Stock | $3,2000 | -0,31% | $215,39M | $1,89M | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6500 | +0,00% | $215,12M | $5,000 | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10,5100 | -0,38% | $214,97M | $50,17K | |
